Catalyst Wire Dossier Catalyst Wire Dossier

MYL-1401A

· Mylan (Mylan Inc.)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MYL-1401A, covering 2022-03-11 to 2022-03-11. Get the full timeline:

Most recent: Clinical Trial Update: MYL-1401A Efficacy and Safety Comparability Study to Humira® [Phase 3]

See pricing